XENETIC BIOSCIENCES, INC. Accounts and Other Receivables, Net, Current
XENETIC BIOSCIENCES, INC. (XBIO) had Accounts and Other Receivables, Net, Current of $0 as of 2015-09-30, per its 10-Q filed 2015-11-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2015-11-16
- 2015-09-30: Accounts and Other Receivables, Net, Current $0.00.
- 2015-06-30: Accounts and Other Receivables, Net, Current $1.72K.
- 2015-03-31: Accounts and Other Receivables, Net, Current $81.09K.
- 2014-12-31: Accounts and Other Receivables, Net, Current $115.78K.
| Period end | Accounts and Other Receivables, Net, Current |
|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-16 |
| 2015-06-30 | $1.72K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $81.09K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $115.78K 10-Q · filed 2015-11-16 |
| 2014-09-30 | $218.37K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $182.76K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $245.74K 10-Q · filed 2014-05-20 |
| 2013-12-31 | $256.01K 10-K · filed 2015-07-20 |
| 2012-12-31 | $81.93K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |